NCT00139165View on ClinicalTrials.gov

Long-Term Treatment of Collagenous Colitis With Budesonide

PHASE3UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2006

Conditions
Collagenous Colitis
Interventions
DRUG

Budesonide

Capsule. Oral 6 mg o.d. for 24 weeks

PROCEDURE

sigmoidoscopy

Sigmoidoscopy performed 2 times during the study period.

Trial Locations (2)

8000

Dept. of medical gastroenterology, Aarhus

9100

Dept. of medical gastroenterology, Aalborg

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Bonderup, Ole K., M.D.

INDIV